RxSight, Inc. (RXST) Tops Q3 EPS by 25c

RxSight, Inc. (NASDAQ: RXST) reported Q3 EPS of $0.00, $0.25 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $35.3 million versus the consensus estimate of $35.06 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• DA Davidson Reiterates Neutral Rating on The Campbell's Co. (CPB)
• SGHC Limited (SGHC) Reiterated at Market Outperform by Citizens: 'Preferred in Gaming Space'